ARGX

NASD argenx SE Sponsored ADR
Oct 12, 2026 · 11:36 PM ET EOD Market Closed

$812.30 ↑ +0.00 (+0.00%) Trading Up from the previous close of $812.30, $20.19 below the day’s high of $832.49

YTD change
-3.41%
vs 20-day SMA
-14.19%
vs 200-day SMA
-4.66%

Price ranges

Previous day
$805.07 $826.78
open $820.93 close $825.03
+$4.10 (+0.50%)
Today
$810.70 $832.49
open $832.33 now $812.30
-$20.03 (-2.41%)
Past week
$787.73 $942.69
from $919.21 now $812.30
-$106.91 (-11.63%)
Past month
$787.73 $1,008.32
from $984.39 now $812.30
-$172.09 (-17.48%)
This year
$661.85 $1,072.75
from $840.95 now $812.30
-$28.65 (-3.41%)

Price & Performance

+3.03 (+0.37%) / 6M

$752.32$862.08$971.85$1,081.61Apr 13Jul 14Oct 12

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 24.3% away from all-time highs of $1,072.75
  • ARGX is down 3% since the beginning of the year
  • ARGX is up 2% over the past 12 months
  • ARGX is down 17% over the past 1 month

ARGX reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +1.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $3.74
Earnings momentum +18.3% Quarterly EPS growth
Quarterly change +18.3%

Valuation

P/E ratio 34.37
Enterprise value $39.4B
Beta 0.38

Balance sheet & scale

Income$1.3M
Revenue$3.1B
Cash$3.9B
Debt$43.2K
Income / Debt 29.71×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $49.7B

argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.

Competitor comparison

TickerCompany PriceChange
CMXHF CSL Limited $121.10 -3.91%
WXXWY WuXi Biologics (Cayman) Inc. Unsponsored ADR $13.55 -1.95%
IVBIY Innovent Biologics, Inc. Unsponsored ADR $54.29 +0.00%
INCY Incyte Corporation $111.36 -1.27%
NBIX Neurocrine Biosciences, Inc. $141.37 -0.75%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.